- ICH GCP
- US Clinical Trials Registry
- Researchers
- Canada
- Hyperlipoproteinemia Type I
Medical specialists from Canada tagged as investigators in clinical trials studying Hyperlipoproteinemia Type I
Total 5 results
-
Daniel Gaudet, MDSeen in:
- Quebec, Chicoutimi, Ecogene-21
Trials:- NCT02135705 (Principal Investigator)
- NCT05089084 (Principal Investigator)
-
Gary Lewis, MDSeen in:
- Ontario, Toronto, Toronto General Hospital
Trials:- NCT05089084 (Principal Investigator)
Conditions: -
Jean Bergeron, MDSeen in:
- Quebec, Québec, Clinique des Maladies Lipidiques de Quebec Inc.
Trials:- NCT05089084 (Principal Investigator)
Conditions: -
Robert Hegele, MDSeen in:
- Ontario, London, Robarts Research Institute
Trials:- NCT02135705 (Principal Investigator)
- NCT05089084 (Principal Investigator)
-
Sophie BERNARD, MDSeen in:
- Quebec, Montreal, Institute de Recherches Cliniques de Montreal
Trials:- NCT05089084 (Principal Investigator)
Conditions:
Clinical Trials on Hyperlipoproteinemia Type I
-
S.LAB (SOLOWAYS)Center of New Medical Technologies; Triangel ScientificCompletedLDL Hyperlipoproteinemia | Low-Density-Lipoprotein-Type [LDL] Hyperlipoproteinemia | Triglyceride Storage Type I or II DiseaseRussian Federation
-
UniQure Biopharma B.V.CompletedLipoprotein Lipase Deficiency | Familial Hyperlipoproteinemia Type 1 | Familial HyperchylomicronemiaGermany
-
University of Texas Southwestern Medical CenterCompletedHypertriglyceridemia | Hyperlipoproteinemia Type IUnited States
-
Akcea TherapeuticsIonis Pharmaceuticals, Inc.CompletedFamilial Chylomicronemia Syndrome | Lipoprotein Lipase Deficiency | Hyperlipoproteinemia Type 1United States, Canada, Germany, Israel, Italy, South Africa, Spain, United Kingdom, Brazil, France, Netherlands
-
Akcea TherapeuticsIonis Pharmaceuticals, Inc.CompletedFamilial Chylomicronemia Syndrome | Lipoprotein Lipase Deficiency | Hyperlipoproteinemia Type 1Canada
-
Amsterdam Molecular TherapeuticsICON plcTerminatedHyperlipoproteinemia Type ICanada
-
AstraZenecaCompletedHypertriglyceridemia | Hyperlipidemia | Hyperlipoproteinemia Type V | Hyperlipoproteinemia Type IV | Hyperlipoproteinemia Type IIbMexico
-
Catabasis PharmaceuticalsCompletedHypertriglyceridemia | Hyperlipoproteinemia Type I | Lipoprotein Lipase Deficiency, Familial | Chylomicronemia, FamilialCanada
-
CENTOGENE GmbH RostockWithdrawnLipoprotein Lipase Deficiency | Inborn Error of Lipid Metabolism | Corneal ArcusGermany, India, Sri Lanka
-
Novartis PharmaceuticalsTerminatedFamilial Chylomicronemia Syndrome (FCS) (HLP Type I)South Africa, Germany, United Kingdom, France, United States, Canada, Netherlands